EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease

Chris-Tiann Roberts iD, Nicole Raabe, Lara Wiegand, Ashraf Kadar Shahib iD, Mojgan Rastegar iD

Pharmaceuticals · 27.11.2024 · 17 (12) · 1601

DOI: 10.3390/ph17121601 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 27.11.2024. Verfasst von Chris-Tiann Roberts und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB …. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research (CIHR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin is a commonly used drug for treating type 2 diabetes. Metformin is an inexpensive drug with low/no side effects and is well tolerated in human patients of different ages. Recent therapeutic strategies for human disease have considered the benefits of drug repurposing. This includes the use of the anti-diabetic drug metformin. Accordingly, the anti-inflammatory, anti-cancer, anti-viral, neuroprotective, and cardioprotective potentials of metformin have deemed it a suitable candidate for treating a plethora of human diseases. As results from preclinical studies using cellular and animal model systems appear promising, clinical trials with metformin in the context of non-diabetes-related illnesses have been started. Here, we aim to provide a comprehensive overview of the therapeutic potential of metformin in different animal models of human disease and its suggested relationship to epigenetics and ailments with epigenetic components.

Schlagwörter

Stichwörter der Autor:innen

drug repurposingepigeneticshuman diseasemetformintype 2 diabetes

Autor:innen und Institutionen

  • Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.

ORCID-Profile: Chris-Tiann Roberts, Ashraf Kadar Shahib, Mojgan Rastegar

Förderung

  • CIHR
  • Canadian Institutes of Health Research (CIHR)

Zitieren

APA

Roberts, C. T., Raabe, N., Wiegand, L., Kadar Shahib, A., & Rastegar, M. (2024). Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease. Pharmaceuticals, 17(12), 1601. https://doi.org/10.3390/ph17121601

Vancouver

Roberts CT, Raabe N, Wiegand L, Kadar Shahib A, Rastegar M. Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease. Pharmaceuticals. 2024;17(12):1601. doi:10.3390/ph17121601

BibTeX
@article{Roberts2024,
  author = {Roberts, Chris-Tiann and Raabe, Nicole and Wiegand, Lara and Kadar Shahib, Ashraf and Rastegar, Mojgan},
  title = {Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {12},
  pages = {1601},
  doi = {10.3390/ph17121601}
}
Kostenlos starten →